MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Cronos Group Inc

Closed

SectorHealthcare

2.49 0.4

Overview

Share price change

24h

Current

Min

2.49

Max

2.5

Key metrics

By Trading Economics

Income

-46M

-38M

Sales

12M

44M

P/E

Sector Avg

51

36.442

Profit margin

-86.961

Employees

459

EBITDA

-35M

-35M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+14.92% upside

Dividends

By Dow Jones

Next Earnings

11 Nov 2025

Market Stats

By TradingEconomics

Market Cap

198M

976M

Previous open

2.09

Previous close

2.49

News Sentiment

By Acuity

100%

0%

358 / 371 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Cronos Group Inc Chart

Past performance is not a reliable indicator of future results.

Related News

17 Oct 2025, 18:13 UTC

Major Market Movers

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17 Oct 2025, 17:05 UTC

Major Market Movers

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

17 Oct 2025, 15:03 UTC

Major Market Movers

Obook Shares Sink Following Public Debut

17 Oct 2025, 14:41 UTC

Major Market Movers

Disc Medicine Shares Surge After FDA Grants Priority Voucher for EPP Drug

17 Oct 2025, 23:25 UTC

Acquisitions, Mergers, Takeovers

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17 Oct 2025, 22:15 UTC

Market Talk

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17 Oct 2025, 21:15 UTC

Market Talk

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17 Oct 2025, 21:07 UTC

Market Talk

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17 Oct 2025, 21:07 UTC

Market Talk

Global Equities Roundup: Market Talk

17 Oct 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 Oct 2025, 20:34 UTC

Market Talk

Deere Is Reaching the End of Its Downcycle -- Market Talk

17 Oct 2025, 20:27 UTC

Market Talk

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17 Oct 2025, 19:46 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17 Oct 2025, 19:45 UTC

Market Talk

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17 Oct 2025, 18:45 UTC

Market Talk

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17 Oct 2025, 17:51 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 Oct 2025, 17:51 UTC

Market Talk

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17 Oct 2025, 17:44 UTC

Market Talk

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17 Oct 2025, 17:35 UTC

Market Talk

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17 Oct 2025, 16:20 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

17 Oct 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 Oct 2025, 16:14 UTC

Market Talk

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17 Oct 2025, 16:04 UTC

Market Talk

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17 Oct 2025, 15:58 UTC

Market Talk

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17 Oct 2025, 15:56 UTC

Earnings

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17 Oct 2025, 15:43 UTC

Market Talk

Global Equities Roundup: Market Talk

17 Oct 2025, 15:43 UTC

Market Talk

Amazon's Earnings Are About Sentiment of Consumers, Not Investors -- Market Talk

17 Oct 2025, 14:58 UTC

Market Talk

Small-Business Trepidation in Canada Points to Economic Decline -- Market Talk

17 Oct 2025, 14:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 Oct 2025, 14:35 UTC

Market Talk
Earnings

American Express's Delayed Card Fee Hike Worries Some Investors -- Market Talk

Peer Comparison

Price change

Cronos Group Inc Forecast

Price Target

By TipRanks

14.92% upside

12 Months Forecast

Average 2.85 USD  14.92%

High 2.847 USD

Low 2.847 USD

Based on 1 Wall Street analysts offering 12 month price targets forCronos Group Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

1 ratings

0

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

1.84 / N/ASupport & Resistance

Short Term

Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

No Evidence

Sentiment

By Acuity

358 / 371 Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Cronos Group Inc

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
help-icon Live chat